Hepatitis C: Diagnosis and Management.
Maness DL, Riley E, Studebaker G.
Am Fam Physician. 2021 Dec 1;104(6):626-635.
EASL recommendations on treatment of hepatitis C: Final update of the series().
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guidelines Panel: Chair:; EASL Governing Board representative:; Panel members:.
J Hepatol. 2020 Nov;73(5):1170-1218. doi: 10.1016/j.jhep.2020.08.018. Epub 2020 Sep 15.
Chronic hepatitis C: Diagnosis and treatment made easy.
Abu-Freha N, Mathew Jacob B, Elhoashla A, Afawi Z, Abu-Hammad T, Elsana F, Paz S, Etzion O.
Eur J Gen Pract. 2022 Dec;28(1):102-108. doi: 10.1080/13814788.2022.2056161.
Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis.
Akhtar E, Manne V, Saab S.
Liver Int. 2015 Jan;35(1):30-6. doi: 10.1111/liv.12576. Epub 2014 May 22.
Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
Pearlman BL.
Dig Dis Sci. 2024 May;69(5):1551-1561. doi: 10.1007/s10620-024-08393-x. Epub 2024 Apr 5.
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025.
Rodríguez-Tajes S, Pocurull A, Castillo J, Casanova G, Vega L, Lens S, Mariño Z, Londoño MC, Forner A, Torres F, Forns X.
J Hepatol. 2020 Dec;73(6):1360-1367. doi: 10.1016/j.jhep.2020.07.018. Epub 2020 Jul 19.
Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis.
Toshikuni N.
Gut Liver. 2017 May 15;11(3):335-348. doi: 10.5009/gnl15458.
Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection.
Weiler N, Zeuzem S, Welker MW.
World J Gastroenterol. 2016 Nov 7;22(41):9044-9056. doi: 10.3748/wjg.v22.i41.9044.
Hepatitis-C Virus and Cirrhosis: An Overview from Khyber Pakhtunkhwa Province of Pakistan.
Ullah A, Rehman IU, Ahmad J, Gohar M, Ahmad S, Ahmad B.
Viral Immunol. 2020 Jun;33(5):396-403. doi: 10.1089/vim.2019.0176. Epub 2020 Feb 28.
Longitudinal multi-omics analyses of the gut-liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis.
Ali RO, Quinn GM, Umarova R, Haddad JA, Zhang GY, Townsend EC, Scheuing L, Hill KL, Gewirtz M, Rampertaap S, Rosenzweig SD, Remaley AT, Han JM, Periwal V, Cai H, Walter PJ, Koh C, Levy EB, Kleiner DE, Etzion O, Heller T.
Nat Microbiol. 2023 Jan;8(1):12-27. doi: 10.1038/s41564-022-01273-y. Epub 2022 Dec 15.
